Ifrah Financial Services’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,474
Closed -$239K 222
2021
Q4
$239K Sell
1,474
-122
-8% -$19.6K 0.06% 197
2021
Q3
$238K Buy
1,596
+92
+6% +$19.1K 0.07% 189
2021
Q2
$368K Sell
1,504
-79
-5% -$20.7K 0.11% 144
2021
Q1
$419K Sell
1,583
-59
-4% -$16.6K 0.13% 140
2020
Q4
$482K Sell
1,642
-29
-2% -$7.44K 0.16% 113
2020
Q3
$395K Sell
1,671
-33
-2% -$7.5K 0.14% 119
2020
Q2
$338K Sell
1,704
-72
-4% -$13.4K 0.12% 134
2020
Q1
$326K Buy
+1,776
New +$316K 0.14% 122

Other funds holding AMED

Ifrah Financial Services's AMED Position: Q1 2022 in Review

Ifrah Financial Services sold out of Amedisys (AMED) in Q1 2022, closing a stake of 1,474 shares — an estimated $239K sold.

Ifrah Financial Services first reported a position in AMED in Q1 2020 and held it in 8 quarters. The position peaked at $482K in Q4 2020. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • Ifrah Financial Services reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • Ifrah Financial Services sold 1,474 Amedisys shares in Q1 2022, an estimated $239K.
  • Ifrah Financial Services first reported a position in Amedisys in Q1 2020 and held it in 8 quarters.
  • Ifrah Financial Services's Amedisys position peaked at $482K in Q4 2020.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Ifrah Financial Services's 13F filing for Q1 2022, filed 3 May 2022.